Page last updated: 2024-11-06

prednisolone and Mucopolysaccharidoses

prednisolone has been researched along with Mucopolysaccharidoses in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Mucopolysaccharidoses: Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desjobert, A1
Larget-Piet, L1

Other Studies

1 other study available for prednisolone and Mucopolysaccharidoses

ArticleYear
Variations in urinary mucopolysaccharides after injection of fibroblasts into patients with mucopolysaccharidoses.
    Clinical chemistry, 1987, Volume: 33, Issue:10

    Topics: Azathioprine; Child; Fibroblasts; Glycosaminoglycans; Hexosamines; Hexuronic Acids; Humans; Iduronic

1987